Evidence map›Paper›PMID 32651195›Full record

ArticleAnnals of the rheumatic diseases2020

Quantitative planar array screen of 1000 proteins uncovers novel urinary protein biomarkers of lupus nephritis.

Kamala Vanarsa, Sanam Soomro, Ting Zhang, Briony Strachan, Claudia Pedroza, Malavika Nidhi, Pietro Cicalese, Christopher Gidley, Shobha Dasari, Shree Mohan and 7 more

Open access · greenAbstract read
In one paragraph

Article in Annals of the rheumatic diseases, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed, 1 pooled it
7.0field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 1 synthesis or guideline pooled it, 66 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Molecular and Cellular Mediators of Renal Fibrosis in Lupus Nephritis.International journal of molecular sciences · 2025
    Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Review
  16. Review
  17. Article
  18. Review
  19. Article
  20. Lupus Nephritis Biomarkers: A Critical Review.International journal of molecular sciences · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 5 institutions in 2 countries.

Kamala VanarsaDepartment of Biomedical Engineering, University of Houston, Houston, Texas, USA.
Sanam SoomroDepartment of Biomedical Engineering, University of Houston, Houston, Texas, USA.
Ting ZhangDepartment of Biomedical Engineering, University of Houston, Houston, Texas, USA.
Briony StrachanDepartment of Biomedical Engineering, University of Houston, Houston, Texas, USA.
Claudia PedrozaCenter for Clinical Research and Evidence-based Medicine, McGovern Medical School, University of Texas Health Science Center at Houston, Houston, Texas, USA.
Malavika NidhiDepartment of Biomedical Engineering, University of Houston, Houston, Texas, USA.
Pietro CicaleseDepartment of Biomedical Engineering, University of Houston, Houston, Texas, USA.
Christopher GidleyDepartment of Biomedical Engineering, University of Houston, Houston, Texas, USA.ORCID 0000-0002-1260-5395
Shobha DasariDepartment of Biomedical Engineering, University of Houston, Houston, Texas, USA.
Shree MohanDepartment of Biomedical Engineering, University of Houston, Houston, Texas, USA.
Nathan ThaiDepartment of Biomedical Engineering, University of Houston, Houston, Texas, USA.
Van Thi Thanh TruongCenter for Clinical Research and Evidence-based Medicine, McGovern Medical School, University of Texas Health Science Center at Houston, Houston, Texas, USA.
Nicole JordanDivision of Rheumatology, Albert Einstein College of Medicine, Bronx, New York, USA.
Ramesh SaxenaDivision of Nephrology, Department of Medicine, UT Southwestern Medical, Dallas, Texas, USA.
Chaim PuttermanDivision of Rheumatology, Albert Einstein College of Medicine, Bronx, New York, USA.
Michelle PetriDivision of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.ORCID 0000-0003-1441-5373
Chandra MohanDepartment of Biomedical Engineering, University of Houston, Houston, Texas, USA cmohan@central.uh.edu.ORCID 0000-0001-7896-5740
University of Houston · USAlbert Einstein College of Medicine · USCenter for Clinical Research (United States) · USJohns Hopkins University · USThe University of Texas Southwestern Medical Center · US

Funding

Convalescent Plasma to Limit Coronavirus Associated ComplicationsUL1TR003167 · NCATS · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI KARP, DANIEL D, MCPHERSON, DAVID D · 2019 to 2023
$45.3M
Institutional Career Development CoreKL2TR003168 · NCATS · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI MILLER, CHARLES C · 2019 to 2023
$4.9M
Monitoring Disease in LupusR01AR074096 · NIAMS · UNIVERSITY OF HOUSTON · PI CHANDRA MOHAN · 2019 to 2026
$4.5M
Hopkins Lupus CohortR01AR069572 · NIAMS · JOHNS HOPKINS UNIVERSITY · PI PETRI, MICHELLE A · 2016 to 2020
$3.4M
NCATS NIH HHS KL2 TR003168NCATS NIH HHS UL1 TR003167NIAMS NIH HHS R01 AR069572NIAMS NIH HHS R01 AR074096
6 · The paper itself

Abstract

objectiveThe goal of these studies is to discover novel urinary biomarkers of lupus nephritis (LN).

methodsUrine from systemic lupus erythematosus (SLE) patients was interrogated for 1000 proteins using a novel, quantitative planar protein microarray. Hits were validated in an independent SLE cohort with inactive, active non-renal (ANR) and active renal (AR) patients, in a cohort with concurrent renal biopsies, and in a longitudinal cohort. Single-cell renal RNA sequencing data from LN kidneys were examined to deduce the cellular origin of each biomarker.

resultsScreening of 1000 proteins revealed 64 proteins to be significantly elevated in SLE urine, of which 17 were ELISA validated in independent cohorts. Urine Angptl4 (area under the curve (AUC)=0.96), L-selectin (AUC=0.86), TPP1 (AUC=0.84), transforming growth factor-β1 (TGFβ1) (AUC=0.78), thrombospondin-1 (AUC=0.73), FOLR2 (AUC=0.72), platelet-derived growth factor receptor-β (AUC=0.67) and PRX2 (AUC=0.65) distinguished AR from ANR SLE, outperforming anti-dsDNA, C3 and C4, in terms of specificity, sensitivity and positive predictive value. In multivariate regression analysis, urine Angptl4, L-selectin, TPP1 and TGFβ1 were highly associated with disease activity, even after correction for demographic variables. In SLE patients with serial follow-up, urine L-selectin (followed by urine Angptl4 and TGFβ1) were best at tracking concurrent or pending disease flares. Importantly, several proteins elevated in LN urine were also expressed within the kidneys in LN, either within resident renal cells or infiltrating immune cells, based on single-cell RNA sequencing analysis.

conclusionUnbiased planar array screening of 1000 proteins has led to the discovery of urine Angptl4, L-selectin and TGFβ1 as potential biomarker candidates for tracking disease activity in LN.

Indexed as

Protein Array AnalysisAngiopoietin-Like Protein 4BiomarkersHumansLupus NephritisTransforming Growth Factor beta1Tripeptidyl-Peptidase 1Angiopoietin-Like Protein 4ANGPTL4 protein, humanBiomarkersTGFB1 protein, humanTPP1 protein, humanTransforming Growth Factor beta1Tripeptidyl-Peptidase 1autoimmunitycytokineslupus nephritissystemic lupus erythematosus

Identifiers

PMID32651195
PMCPMC7839323
OpenAlexW3042140023

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.